In summary, our study provides new insights into the mechanisms of SCLC tumorigenesis by uncovering the unexpected role of CRACD, an actin regulator, in limiting cell plasticity and inhibiting tumor immune evasion. The gene discussed is CRACD; the disease is small cell lung carcinoma.